| activation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| amyloid fibril formation |
The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. |
| apoptotic mitochondrial changes |
The morphological and physiological alterations undergone by mitochondria during apoptosis. |
| apoptotic process involved in mammary gland involution |
Any apoptotic process that triggers the activity of proteolytic caspases whose actions dismantle the mammary epithelial cells resulting in their programmed cell death. |
| cell cycle |
The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| cellular response to glucose stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
| cellular response to hydrogen peroxide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| cellular senescence |
A cell aging process stimulated in response to cellular stress, whereby normal cells lose the ability to divide through irreversible cell cycle arrest. |
| cerebellum development |
The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills. |
| epidermis development |
The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. |
| glucose homeostasis |
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
| mammary gland epithelial cell proliferation |
The multiplication or reproduction of mammary gland epithelial cells, resulting in the expansion of a cell population. Mammary gland epithelial cells make up the covering of surfaces of the mammary gland. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. |
| negative regulation of B cell proliferation |
Any process that stops, prevents or reduces the rate or extent of B cell proliferation. |
| negative regulation of cell cycle |
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| negative regulation of cell growth |
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| negative regulation of cell population proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| negative regulation of cell-matrix adhesion |
Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix. |
| negative regulation of cyclin-dependent protein serine/threonine kinase activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity. |
| negative regulation of DNA-templated transcription |
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| negative regulation of hepatocyte proliferation |
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte proliferation. |
| negative regulation of immature T cell proliferation in thymus |
Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus. |
| negative regulation of mammary gland epithelial cell proliferation |
Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation. |
| negative regulation of NF-kappaB transcription factor activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| negative regulation of phosphorylation |
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. |
| negative regulation of protein binding |
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| negative regulation of protein kinase activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity. |
| negative regulation of protein neddylation |
Any process that stops, prevents or reduces the frequency, rate or extent of protein neddylation. |
| negative regulation of proteolysis involved in protein catabolic process |
Any process that stops, prevents or reduces the frequency, rate or extent of proteolysis involved in protein catabolic process. |
| negative regulation of ubiquitin protein ligase activity |
Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin protein ligase activity. |
| negative regulation of ubiquitin-dependent protein catabolic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process. |
| negative regulation of ubiquitin-protein transferase activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity. |
| neurogenesis |
Generation of cells within the nervous system. |
| positive regulation of apoptotic process |
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| positive regulation of apoptotic process involved in mammary gland involution |
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process of mammary epithelial cells during mammary gland involution. |
| positive regulation of DNA-binding transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| positive regulation of DNA-templated transcription |
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of macrophage apoptotic process |
Any process that activates or increases the frequency, rate or extent of macrophage apoptotic process. |
| positive regulation of protein sumoylation |
Any process that activates or increases the frequency, rate or extent of the addition of SUMO groups to a protein. |
| positive regulation of smooth muscle cell apoptotic process |
Any process that activates or increases the frequency, rate, or extent of smooth muscle cell apoptotic process. |
| positive regulation of transcription by RNA polymerase II |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| protein destabilization |
Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. |
| protein K63-linked ubiquitination |
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair. |
| protein polyubiquitination |
Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain. |
| protein stabilization |
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| Ras protein signal transduction |
The series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
| regulation of apoptotic DNA fragmentation |
Any process that modulates the frequency, rate or extent of apoptotic DNA fragmentation. |
| regulation of cell cycle |
Any process that modulates the rate or extent of progression through the cell cycle. |
| regulation of cyclin-dependent protein serine/threonine kinase activity |
Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity. |
| regulation of DNA-binding transcription factor activity |
Any process that modulates the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| regulation of G1/S transition of mitotic cell cycle |
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. |
| regulation of G2/M transition of mitotic cell cycle |
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle. |
| regulation of gene expression |
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| regulation of nucleocytoplasmic transport |
Any process that modulates the frequency, rate or extent of the directed movement of substances between the nucleus and the cytoplasm. |
| regulation of protein stability |
Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
| replicative senescence |
A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging. |
| response to caloric restriction |
A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caloric restriction, insufficient food energy intake. |
| response to fatty acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus. |
| response to organic cyclic compound |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| response to organic substance |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| response to organonitrogen compound |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond. |
| response to salt stress |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment. |
| response to xenobiotic stimulus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
| rRNA processing |
Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules. |
| rRNA transcription |
The synthesis of ribosomal RNA (rRNA), any RNA that forms part of the ribosomal structure, from a DNA template. |
| somatic stem cell division |
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line. |
| somatic stem cell population maintenance |
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line. |